oppn parties Patanjali Corona Kit: False Claims To Cash-In On Health Fears

News Snippets

  • In a first, the Supreme Court recognizes marital rape, although for the limited purpose of allowing married women the right of abortion up to 24 weeks if they conceived as a result of forced sex by their husbands
  • Air India cuts discounts on base fare to students and senior citizens from 50% to 25%
  • Mallikarjun Kharge and Digvijay Singh are being touted as frontrunners to take on Shashi Tharoor in the elections for the post of Congress president
  • Sonia Gandhi will decide who will be Rajasthan CM if she feels there is a need to change guard after the near-rebellion by MLAs in the state
  • Ashok Gehlot bowed out of the race for being Congress president after meeting Sonia Gandhi
  • India has moved to the 40th spot in the innovation index, up 6 spots from last year
  • DGGI has alleged that top insurance companies, banks and NBFCs has committed a fraud of Rs 800cr by claiming input tax credit without underlying supplies
  • The Centre will borrow Rs 10000cr less than planned earlier due to good revenue collections
  • At $23.9bn, India's current account deficit widened to 2.8% in Q1, the worst in four years
  • Stocks continue to flounder on Thursday: Sensex sheds 188 points to 56409 and Nifty 40 points to 16818
  • The 36th National Games were declared open on Thusrday by PM Modi in front of a record crowd in Motera near Ahmedabad
  • Jasprit Bumrah most likely to miss T20 World Cup due to recurrence of back injury
  • PFI's political wing, the SDPI is on EC radar and action will follow soon if discrepancies are detected
  • Ashok Gehlot to meet Sonia Gandhi today, says all issues will be sorted out soon
  • Referring to the PFI ban, most Muslim organizations ask the government to take similar action against right wings organizations like the RSS, Bajrang Dal, VHP and the like
In a landmark order, Supreme Court rules that all women, married or unmarried, are entitled to safe and legal abortion up to 24 weeks of pregnancy as per the MTP Act
oppn parties
Patanjali Corona Kit: False Claims To Cash-In On Health Fears

By A Special Correspondent
First publised on 2020-06-25 13:42:45

Ramdev's Patanjali has released an ayurvedic formulation Coronil (being sold as a kit along with two other formulations, priced at Rs 545) which it claims is the first ayurvedic medicine for Covid-19. The government has asked it to stop making the erroneous claim. The Uttarakhand government has issued a clarification saying that Patanjali had applied for a license for making a medicine for boosting immunity, cough and fever which was granted to it. It also said that a notice has been issued to the company asking it to reply to why it was claiming that the drug cured Covid-19. States like Rajasthan and Maharashtra have already banned the sale of the formulation and more states are likely to do so.

It was unethical for Patanjali to make such a claim without proper trials and verification by drug bodies or the Ayush ministry of the government of India. By trying to cash in on the pandemic, Patanjali has shown that it is like other profit-minded pharma companies despite flaunting its credentials as a company rooted in making drugs as per ancient Hindu medicinal texts. It is beyond one's comprehension as to how ancient ayurveda texts could have anticipated the Covid-19 virus and prescribed a formulation to treat it. It should have promoted the drug for what it was - an immunity booster.

It is good that the Centre as well as the states have taken immediate steps to call its bluff and ask for an explanation. With citizens worried about their health due to the pandemic, such companies cannot be allowed to feed on this and fill their coffers by making false claims. Since people are trying a host of home remedies to boost immunity and since Patanjali has brand value, it is obvious that if the government does not step in to stop the sale of the dubious medicine there will be many takers for it. Patanjali should be asked to reposition the kit as one for boosting immunity and change its name before releasing it in the market.